يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Proteasome endopeptidase complex"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    كتاب

    المساهمون: Bursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Moleküler Biyoloji ve Genetik Bölümü., Tepedelen, Burcu Erbaykent, CNH-6913-2022, 47860936500

    العلاقة: SBAG-108S056/114S062; Makale - Uluslararası Hakemli Dergi; Advances in Experimental Medicine and Biology; Yurt içi; Kırmızıbayrak, P. B. vd. (2020). "Divergent modulation of proteostasis in prostate cancer". ed. R. Barrio vd. Advances in Experimental Medicine and Biology, 1233, 117-151.; https://doi.org/10.1007/978-3-030-38266-7_5Test; https://link.springer.com/chapter/10.1007/978-3-030-38266-7_5Test; http://hdl.handle.net/11452/30992Test; 000530838600006; 2-s2.0-85083257850; 117; 151; 1233

  2. 2
    دورية أكاديمية

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı., orcid:0000-0003-4875-5472, Ulukaya, Engin, K-5792-2018, 6602927353

    وصف الملف: application/pdf

    العلاقة: SBAG 109S035; Makale - Uluslararası Hakemli Dergi; Journal of Proteomics; Yurt içi; Yerlikaya, A. vd. (2015). "A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line". Journal of Proteomics, 113, 315-325.; https://doi.org/10.1016/j.jprot.2014.09.010Test; https://www.sciencedirect.com/science/article/pii/S1874391914004266Test; http://hdl.handle.net/11452/34162Test; 000347582200022; 2-s2.0-84938493066; 315; 325; 113

  3. 3
    دورية أكاديمية

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı., orcid:0000-0003-4875-5472, Ulukaya, Engin, K-5792-2018, 6602927353

    وصف الملف: application/pdf

    العلاقة: SBAG 109S035; Makale - Uluslararası Hakemli Dergi; Journal of Proteomics; Yurt içi; Yerlikaya, A. vd. (2015). "A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line". Journal of Proteomics, 113, 315-325.; https://doi.org/10.1016/j.jprot.2014.09.010Test; https://www.sciencedirect.com/science/article/pii/S1874391914004266Test; http://hdl.handle.net/11452/34162Test; 000347582200022; 2-s2.0-84938493066; 315; 325; 113

  4. 4
    مراجعة

    المؤلفون: Yerlikaya, Azmi

    المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/İmmünoloji Anabilim Dalı., orcid:0000-0001-8399-8942, Kanbur, Ertan, AAW-6971-2021, 57218292727

    العلاقة: Makale - Uluslararası Hakemli Dergi; Current Drug Targets; Yurt içi; Yerlikaya, A. ve Kanbur, E. (2020). "The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells". Current Drug Targets, 21(13), 1313-1325.; https://doi.org/10.2174/1389450121666200525004714Test; https://pubmed.ncbi.nlm.nih.gov/32448101Test/; http://hdl.handle.net/11452/34729Test; 000581913300004; 2-s2.0-85091720797; 1313; 1325; 21; 13

  5. 5
    مراجعة

    المؤلفون: Yerlikaya, Azmi

    المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/İmmünoloji Anabilim Dalı., orcid:0000-0001-8399-8942, Kanbur, Ertan, AAW-6971-2021, 57218292727

    العلاقة: Makale - Uluslararası Hakemli Dergi; Current Drug Targets; Yurt içi; Yerlikaya, A. ve Kanbur, E. (2020). "The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells". Current Drug Targets, 21(13), 1313-1325.; https://doi.org/10.2174/1389450121666200525004714Test; https://pubmed.ncbi.nlm.nih.gov/32448101Test/; http://hdl.handle.net/11452/34729Test; 000581913300004; 2-s2.0-85091720797; 1313; 1325; 21; 13